News

Emergent BioSolutions to buy Trubion Pharma for up to $135.5 million; reaffirms 2010 guidance

16-08-2010

US vaccine maker Emergent BioSolutions has entered into a definitive agreement to acquire Trubion Pharmaceuticals,…

BiotechnologyEmergent BioSolutionsImmunologicalsMergers & AcquisitionsOncologyPharmaceuticalTrubion PharmaceuticalsVaccines

COMPANY SPOTLIGHT

Menarini

Back to top